Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | ALPA Alpa Laboratories Limited Pharma · Small | AMBALALSA Ambalal Sarabhai Enterprises Limited Pharma · Small | AAREYDRUGS Aarey Drugs & Pharmaceuticals Limited Pharma · Small | BALPHARMA Bal Pharma Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 46 | 45 | 15 | 19 |
| Verdict | FAIR VALUE | WATCHLIST | OVERVALUED | OVERVALUED |
| Style | Deep Value | Financial Turnaround | OVERVALUED | Distress Watch |
| Piotroski | 6/9 | 7/9 | 6/9 | 6/9 |
| Valuation | 26/30 | 17/30 | 3/30 | 7/30 |
| Growth | 11/25 | 12/25 | 2/25 | 8/25 |
| Quality | 0/20 | 2/20 | 0/20 | 0/20 |
| Balance Sheet | 10/15 | 7/15 | 6/15 | 0/15 |
| Cash Flow | 4/10 | 5/10 | 4/10 | 9/10 |
| Price | ₹69.36 | ₹34.3 | ₹80.24 | ₹87.79 |
| P/E | 9.57 | 14.20 | 55.60 | 21.60 |
| P/B | 0.77 | 1.67 | 1.47 | 1.65 |
| ROE | 8.39% | 12.40% | 2.75% | 7.87% |
| ROCE | 9.42% | 11.50% | 5.58% | 9.69% |
| Debt / Equity | 0.02 | 0.36 | 0.33 | 1.95 |
| FCF Yield | — | 1.14% | — | 6.67% |
| Dividend Y | — | — | — | 1.41% |
| Altman Z | 3.25 | 2.77 | 3.33 | 1.71 |
| Promoter % | 57.19% | 31.36% | 37.71% | 50.87% |
| Mkt Cap (₹Cr) | 144.00 | 264.00 | 221.00 | 135.00 |
| Graham # | ₹119.15 | ₹32.87 | ₹40.86 | ₹67.63 |
| Fair PE | 42.0 | 42.3 | 4.2 | 16.1 |
| MoS % | +76.8% | +65.1% | -1261.3% | -38.7% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startALPA61
AMBALALSA97
AAREYDRUGS125
BALPHARMA71